Please wait while we open this resource.
K
Clinical reviews
REAL-WORLD STUDY OF INTRANASAL KETAMINE FOR USE IN PATIENTS WITH REFRACTORY CHRONIC MIGRAINE: A RETROSPECTIVE ANALYSIS
Thomas Jefferson University, OhioHealth, Rush University
PDF7 pages423 KB
The research was conducted at a single tertiary headache center and involved candidates who received intranasal ketamine between January 2019 and February 2020. The study aimed to assess the clinical effectiveness and adverse events associated with intranasal ketamine for outpatient care in patients suffering from refractory chronic migraines. It highlights the potential of intranasal ketamine as a convenient alternative for managing severe headache conditions.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Traumatic Brain Injury
Same clinical topic · Neurology
Classification of the Epilepsies
Same clinical topic · Neurology
Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Same clinical topic · Neurology
An update on management of subarachnoid haemorrhage
Same clinical topic · Neurology
INCLUSION BODY MYOSITIS
Same clinical topic · Neurology
ENCEPHALITIS
Same clinical topic · Neurology
INTRACEREBRAL HAEMORRHAGE
Same clinical topic · Neurology
INCLUSION BODY MYOSITIS
Same clinical topic · Neurology
PREVENTION OF STROKE
Same clinical topic · Neurology